[Meditip News Letter 발간수기 873호] 첨단바이오 신약도 수수료 오른다…중소기업은 50% 감면 2026.07.07 [Meditip News Letter 발간수기 873호] 바로가기 Previous post No previous posts available. Next post [No. 872] MFDS Conducts Its First International Joint Review of Pharmaceuticals with Overseas Regulatory Authorities, Including Europe View list
[Meditip News Letter 발간수기 873호] 첨단바이오 신약도 수수료 오른다…중소기업은 50% 감면 2026.07.07 [Meditip News Letter 발간수기 873호] 바로가기 Previous post No previous posts available. Next post [No. 872] MFDS Conducts Its First International Joint Review of Pharmaceuticals with Overseas Regulatory Authorities, Including Europe View list
